search
Back to results

Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency (CCSVI)

Primary Purpose

Multiple Sclerosis

Status
Completed
Phase
Phase 1
Locations
Poland
Study Type
Interventional
Intervention
balloon angioplasty and/or stenting
balloon angioplasty and/or stenting
Sponsored by
Euromedic Specialist Clinics, Poland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Multiple Sclerosis focused on measuring multiple sclerosis, venous insufficiency

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients with clinically defined multiple sclerosis

Exclusion Criteria:

  • contraindication for endovascular procedure performed in local anesthesia

Sites / Locations

  • Euromedic Specialist Clinics

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Balloon angioplasty and/or stenting

Arm Description

Balloon angioplasty and/or stenting of stenosed internal jugular vein and/or azygous vein and/or brachiocephalic vein

Outcomes

Primary Outcome Measures

Change in clinical symptoms of multiple sclerosis measured by Extended Disability Severity Score (EDSS), Multiple Sclerosis Impact Scale-29 (MSIS-29), Fatigue Severity Scale (FSS) and heat intolerance

Secondary Outcome Measures

Full Information

First Posted
December 21, 2010
Last Updated
February 9, 2015
Sponsor
Euromedic Specialist Clinics, Poland
search

1. Study Identification

Unique Protocol Identification Number
NCT01264848
Brief Title
Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency (CCSVI)
Official Title
Endovascular Correction of Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Evaluation of Influence of These Treatments on the Symptoms of Multiple Sclerosis
Study Type
Interventional

2. Study Status

Record Verification Date
February 2015
Overall Recruitment Status
Completed
Study Start Date
March 2010 (undefined)
Primary Completion Date
October 2010 (Actual)
Study Completion Date
December 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Euromedic Specialist Clinics, Poland

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to assess the efficacy of endovascular treatment (balloon angioplasty and/or stenting) for the improvement of clinical symptoms in multiple sclerosis patients.
Detailed Description
The aim of this study is to assess the efficacy of endovascular treatment (balloon angioplasty and/or stenting) for the improvement of clinical symptoms in multiple sclerosis patients measured by Extended Disability Severity Score (EDSS), Multiple Sclerosis Impact Scale-29 (MSIS-29), Fatigue Severity Scale (FSS) and heat intolerance

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis
Keywords
multiple sclerosis, venous insufficiency

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Balloon angioplasty and/or stenting
Arm Type
Experimental
Arm Description
Balloon angioplasty and/or stenting of stenosed internal jugular vein and/or azygous vein and/or brachiocephalic vein
Intervention Type
Procedure
Intervention Name(s)
balloon angioplasty and/or stenting
Intervention Description
balloon angioplasty and/or stenting of internal jugular veins and/or azygous vein and/or brachiocephalic veins
Intervention Type
Procedure
Intervention Name(s)
balloon angioplasty and/or stenting
Intervention Description
balloon angioplasty and/or stenting of extracranial vein draining the central nervous system, on condition that such outflow pathology has been confirmed using catheter venography
Primary Outcome Measure Information:
Title
Change in clinical symptoms of multiple sclerosis measured by Extended Disability Severity Score (EDSS), Multiple Sclerosis Impact Scale-29 (MSIS-29), Fatigue Severity Scale (FSS) and heat intolerance
Time Frame
6 months after the procedure

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients with clinically defined multiple sclerosis Exclusion Criteria: contraindication for endovascular procedure performed in local anesthesia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marian Simka
Organizational Affiliation
Euromedic Specialist Clinics , Katowice , Poland
Official's Role
Principal Investigator
Facility Information:
Facility Name
Euromedic Specialist Clinics
City
Katowice
Country
Poland

12. IPD Sharing Statement

Learn more about this trial

Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency (CCSVI)

We'll reach out to this number within 24 hrs